Anemia
1,054
58
82
683
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
228 trials with published results (22%)
Research Maturity
683 completed trials (65% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
10.4%
110 terminated out of 1054 trials
86.1%
-0.4% vs benchmark
33%
350 trials in Phase 3/4
33%
228 of 683 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 683 completed trials
Clinical Trials (1054)
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Personalizing Preterm Neonatal Transfusions With Fetal Hemoglobin-Enriched Cord Blood
Research Platform Myelofibrosis and Anemia
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
RBC Irradiation, Anemia and Gut Injury
The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion
Daily and Weekly Iron Supplementation in Infants
The Effects of Intravenous Iron on Mobility in Elderly Patients Following Hip Fracture Surgery
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy
Long-term Effectiveness and Implementation of the Meals, Education, and Gardens for In-School Adolescents Program
Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO
INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders
mHealth Integrated Model of Hypertension, Diabetes and Antenatal Care in India and Nepal
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
Improved Child Nutrition and Development Through Social Transfers
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
Anemia and Duration of Mechanical Ventilation